DIAN-TU-001: A Phase II/III Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of 2 Potential Disease Modifying Therapies in Individuals at Risk for and with Dominantly Inherited Alzheimer’s Disease

Principal Investigator: Joy Snider, MD, PhD